ESC 2013 Report – Neither up nor down: Two big trials of DPP-4 inhibitors meet non-inferiority ischemic target
Study presenter Deepak Bhatt (pictured) – The anti-hyperglycemic agent saxagliptin neither increased or decreased therate of ischemic events when added to standard of care in patients with type… read more.
